Annual EBITDA
-$20.94 M
-$4.07 M-24.09%
December 1, 2024
Summary
- As of February 27, 2025, KRBP annual EBITDA is -$20.94 million, with the most recent change of -$4.07 million (-24.09%) on December 1, 2024.
- During the last 3 years, KRBP annual EBITDA has risen by +$4.17 million (+16.59%).
- KRBP annual EBITDA is now -575.15% below its all-time high of -$3.10 million, reached on December 31, 2018.
Performance
KRBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.16 M
+$791.00 K+13.30%
December 1, 2024
Summary
- As of February 27, 2025, KRBP quarterly EBITDA is -$5.16 million, with the most recent change of +$791.00 thousand (+13.30%) on December 1, 2024.
- Over the past year, KRBP quarterly EBITDA has increased by +$791.00 thousand (+13.30%).
- KRBP quarterly EBITDA is now -1981.11% below its all-time high of -$247.80 thousand, reached on June 30, 2019.
Performance
KRBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$20.94 M
-$1.65 M-8.58%
December 1, 2024
Summary
- As of February 27, 2025, KRBP TTM EBITDA is -$20.94 million, with the most recent change of -$1.65 million (-8.58%) on December 1, 2024.
- Over the past year, KRBP TTM EBITDA has dropped by -$1.65 million (-8.58%).
- KRBP TTM EBITDA is now -5628.04% below its all-time high of -$365.50 thousand, reached on March 31, 2019.
Performance
KRBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRBP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.1% | +13.3% | -8.6% |
| 3 y3 years | +16.6% | +12.3% | +24.8% |
| 5 y5 years | -478.8% | +12.3% | +24.8% |
KRBP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.1% | +36.3% | -61.5% | +54.5% | -26.7% | +43.5% |
| 5 y | 5-year | -478.8% | +36.3% | -183.5% | +54.5% | -478.7% | +43.5% |
| alltime | all time | -575.1% | +36.3% | -1981.1% | +54.5% | -5628.0% | +43.5% |
Kiromic BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$20.94 M(+24.1%) | -$5.16 M(-13.3%) | -$20.94 M(+8.6%) |
| Sep 2024 | - | -$5.95 M(+12.0%) | -$19.28 M(+16.7%) |
| Jun 2024 | - | -$5.31 M(+17.5%) | -$16.53 M(-3.3%) |
| Mar 2024 | - | -$4.52 M(+29.0%) | -$17.10 M(+1.3%) |
| Dec 2023 | -$16.88 M(-48.7%) | -$3.50 M(+9.7%) | -$16.88 M(-14.4%) |
| Sep 2023 | - | -$3.19 M(-45.7%) | -$19.73 M(-29.2%) |
| Jun 2023 | - | -$5.88 M(+36.7%) | -$27.86 M(-7.2%) |
| Mar 2023 | - | -$4.30 M(-32.3%) | -$30.01 M(-8.8%) |
| Dec 2022 | -$32.89 M(+31.0%) | -$6.35 M(-43.9%) | -$32.89 M(-11.2%) |
| Sep 2022 | - | -$11.32 M(+40.9%) | -$37.03 M(+16.8%) |
| Jun 2022 | - | -$8.03 M(+11.9%) | -$31.70 M(+11.1%) |
| Mar 2022 | - | -$7.18 M(-31.6%) | -$28.53 M(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$25.11 M(+32.2%) | -$10.49 M(+75.1%) | -$25.11 M(+38.8%) |
| Sep 2021 | - | -$5.99 M(+23.2%) | -$18.09 M(+25.1%) |
| Jun 2021 | - | -$4.87 M(+29.6%) | -$14.47 M(-30.9%) |
| Mar 2021 | - | -$3.76 M(+7.9%) | -$20.93 M(+10.2%) |
| Dec 2020 | -$19.00 M(+425.1%) | -$3.48 M(+47.1%) | -$19.00 M(+7.6%) |
| Sep 2020 | - | -$2.37 M(-79.1%) | -$17.66 M(+9.3%) |
| Jun 2020 | - | -$11.33 M(+523.0%) | -$16.16 M(+218.6%) |
| Mar 2020 | - | -$1.82 M(-15.2%) | -$5.07 M(+40.2%) |
| Dec 2019 | -$3.62 M(+16.6%) | -$2.15 M(+149.9%) | -$3.62 M(+145.8%) |
| Sep 2019 | - | -$858.80 K(+246.6%) | -$1.47 M(+140.0%) |
| Jun 2019 | - | -$247.80 K(-32.2%) | -$613.30 K(+67.8%) |
| Mar 2019 | - | -$365.50 K | -$365.50 K |
| Dec 2018 | -$3.10 M | - | - |
FAQ
- What is Kiromic BioPharma annual EBITDA?
- What is the all time high annual EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma annual EBITDA year-on-year change?
- What is Kiromic BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly EBITDA year-on-year change?
- What is Kiromic BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma TTM EBITDA year-on-year change?
What is Kiromic BioPharma annual EBITDA?
The current annual EBITDA of KRBP is -$20.94 M
What is the all time high annual EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high annual EBITDA is -$3.10 M
What is Kiromic BioPharma annual EBITDA year-on-year change?
Over the past year, KRBP annual EBITDA has changed by -$4.07 M (-24.09%)
What is Kiromic BioPharma quarterly EBITDA?
The current quarterly EBITDA of KRBP is -$5.16 M
What is the all time high quarterly EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly EBITDA is -$247.80 K
What is Kiromic BioPharma quarterly EBITDA year-on-year change?
Over the past year, KRBP quarterly EBITDA has changed by +$791.00 K (+13.30%)
What is Kiromic BioPharma TTM EBITDA?
The current TTM EBITDA of KRBP is -$20.94 M
What is the all time high TTM EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM EBITDA is -$365.50 K
What is Kiromic BioPharma TTM EBITDA year-on-year change?
Over the past year, KRBP TTM EBITDA has changed by -$1.65 M (-8.58%)